Latest Blogs

Aug 05, 2020
Hospitals and clinics are restricting visitors to limit the risk of exposure to COVID-19, but this precaution can be difficult for family caregivers who are struggling to get the information they need to help their loved ones.
Aug 04, 2020
Ahead of the ASCO20 Virtual Education Program, Mr. David Whitaker of Choose Chicago sends his best wishes and gratitude on behalf of the city where the ASCO Annual Meeting is traditionally held.
Jul 27, 2020
Ten years after losing my mom to breast cancer, I find myself reflecting on who I am today and what I have learned from the loss and grief that propelled me to relocate across the globe and dedicate my career to serving patients with cancer. 
Jul 23, 2020
Sometimes the best treatment isn't a medical intervention, but an emotional one, as Dr. Dawood Findakly discovered when a patient seemed to lose his will to live.
Subscribe to this column

L. Michael Glode, MD, FACP, FASCO

L. Michael Glodé, MD, FACP, FASCO, is a Professor Emeritus at the University of Colorado Cancer Center. He previously served as Chair of ASCO's Integrated Media and Technology and Cancer Education Committees. He is the author of prost8blog, a blog to help patients and their families understand various aspects of prostate cancer.

Apr 01, 2020
The TMPRSS2 protein has a role in both COVID-19 and in prostate cancer, suggesting intriguing avenues of inquiry for researchers engaged in the fight against COVID-19.
Sep 09, 2019
A recent study on the risk of Alzheimer's disease or dementia following the use of ADT was disturbing to me on two levels.
Jul 02, 2019
Regardless of prognosis, we all must live with the reality that time is fleeting, and none of us have unlimited tomorrows.
Aug 31, 2018
Some reflections on John McCain, mortality, Hamilton, and the story you leave behind. 
Dec 21, 2016
I cannot count the number of times I have thought to myself, “If it were not for the PSA, you would no doubt be out there playing golf, skiing, biking, taking a grandchild to the park, or just enjoying life.” Living from one PSA to the next is a bad way to mark the passing of time.
Aug 08, 2016
For prostate cancer, there are both challenges and some early positive results from immunotherapy trials that remain intriguing. One of the key challenges is identifying those patients who will benefit from the treatment.

Pages